Master's Thesis
Human motor units in microfluidic devices to study the therapeutic effects of targeting genetic modifiers in FUS-ALS
— 2022
Key information
Authors:
Supervisors:
Published in
November 30, 2022
Abstract
Amyotrophic lateral sclerosis (ALS) is a fatal and progressive disorder characterized by motor neuron (MN) degeneration. Neuromuscular junctions (NMJs) ensure communication between MNs and skeletal muscle, and these structures are lost early in the disease. This leads to muscle atrophy and paralysis. Increasing evidence shows that genetic modifiers contribute to the high phenotypical heterogeneity seen in the clinic. As possible pathology contributors, genetic modifiers are potential therapeutic targets. This study aimed to set up a human motor unit system to study FUS-ALS. Human induced pluripotent stem cell (hiPSC)-derived MNs were co-cultured with human-derived myotubes in microfluidic devices. Their interaction resulted in NMJ-like structure formation. When compared to the isogenic controls, NMJ numbers and neurite outgrowth on the myotube compartment were impaired in the FUS-ALS system, due to the FUS P525L mutation present in the MNs. As a therapeutic strategy, the inhibition of the genetic modifiers (A) and (B) was accessed. (A) inhibition by (A’) rescued NMJ numbers, with no significant rescue on neurite outgrowth. No beneficial results were seen with (B) inhibition by (B’). Altogether, a human-derived in vitro FUS-ALS model was successfully set up. This model prompted drug testing, which highlighted (A) inhibition as a promising therapeutic approach for the disease.
Publication details
Authors in the community:
Adriana Margarida Barbosa Correia
ist189722
Supervisors of this institution:
Fields of Science and Technology (FOS)
industrial-biotechnology - Industrial Biotechnology
Publication language (ISO code)
eng - English
Rights type:
Embargo lifted
Date available:
September 24, 2023
Institution name
Instituto Superior Técnico